In Vitro Performance of Carbamazepine Loaded to Various Molecular Weights of Poly (D, L-Lactide-Co-Glycolide)

REFERENCES

• Allémann E., Leroux J C., Gurny R. Biodegradable nanoparticles of poly(lactic acid) and poly(lactic-co-glycolic acid) for parenteral administration. Pharmaceutical Dosage Forms: Disperse Systems, H. A. Lieberman, M. M. Rieger, G. S. Banker. Marcel Dekker, New York 1998
   Google Scholar
• Annegers J. F. Epidemiology of epilepsy. The treatment of Epilepsy: Principles and Practice, 2nd ed, E. Wyllie. Williams & Wilkins, Baltimore 1997; 165–172
   Google Scholar
• Arshady R. Preparation of biodegradable microspheres and microcapsules: Polylactides and related polyesters. J. Control. Rel. 1991; 17: 1–22, [CSA]
   Web of Science ®Google Scholar
• Barakat N. S., Elbagory I. M., Almurshedi A. S. (2003) Evaluation of prolonged release carbamazepine granules prepared from lipophilic matrices. 6th Saudi Pharmaceutical International Conference. October, 6–92003
   Google Scholar
• Brannon-P L. Recent advances on the use of biodegradable microparticles and nanoparticles in controlled drug delivery. Int. J. Pharmaceut. 1995; 116 1–9, [CROSSREF], [CSA]
   Web of Science ®Google Scholar
• Bodmeier R. Polimeric microparticles prepared by solvent evaporation and spray-drying techniques. Third European Symposium on Controlled Drug Delivery, The Netherlands, 1994; 45–48
   Google Scholar
• Chandrashekar G., Udupa N. Biodegradable injectable implant systems for long term drug delivery using poly(Lactide-co-glycolic) and copolymers. J. Pharm. Pharmacol. 1996; 48: 669–674, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Clas S. D., Dalton C. R., Hancock B. C. Differential scanning calorimetry: applications in drug development. Pharmaceut. Sci. Tech. Today 1999; 2: 311–320, [CROSSREF], [CSA]
   PubMedGoogle Scholar
• DeVane L. Fundamentals of monitoring psychoactive drug therapy in drug therapy for mood disorders (E) intraclass comparisons of antidepressants and mood stabilizers. Williams & Wilkins, Baltimore 1990; 128–130
   Google Scholar
• Dunn R. L., English J. P., Strobel J. D., Cowsar D. R., Tice T. R. Preparation and evaluation of Lactide/glycolide co-polymers for drug delivery. Polymers in Medicine III, C. Migliaresi. Elsevier, Amesterdam 1988; 98–161
   Google Scholar
• Elkheshen S. A., Radwan M. A. Sustained release microspheres of metoclopramide using poly (D,L-lactide-co-glycolide) copolymers. J. Microencap. 2000; 17: 425–435, [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Fathy M., Hassan M. A., Mohamed F. A. Differential scanning calorimetry to investigate the compatibility of ciprofloxacin hydrochloride with excipients. Pharmazie 2002; 57: 825–828, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Garnett W. R., Levy B., McLean A. M., et al. Pharmacokinetic evaluation of twice-daily extended-release carbamazepine (CBZ) and four-times-daily immediate-release CBZ in patients with epilepsy. Epilepsia 1998; 39: 274–279, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Giunchedi P., Maggi U., Conte U., La Manna A. Linear extended release of water insoluble drug, carbamazepine, from erodible matrices. Int. J. Pharmaceut 1993; 94: 15–22, [CROSSREF], [CSA]
   Web of Science ®Google Scholar
• Hsu Y. Y., Gresser J. D., Stewart R. R., Trantolo D. J., Lyons C. M., Simons G. A., Gangadharam P. R. J., Wise D. L. Mechanism of izoniazid release from poly (d,l-lactide-co-glycolide) matrices prepared by dry mixing and low density polymeric foam methods. J. Pharmaceut. Sci. 1996; 85: 706–713, [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Ike O., Schimizu Y., Wada R., Hyon S. H., Ikada Y. Controlled cisplatin delivery system using poly(d, L-Lactic acid). Biomaterials 1992; 13: 230–234, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Ikinici G., Capan Y., Senel S., Dalkara T., Hincal A. A. Formulation and in-vitro/in-vivo investigation of carbamazepine controlled-release matrix tablets. Pharmazie 1999; 54: 139–141, [CSA]
   PubMed Web of Science ®Google Scholar
• Jain R., Shah N. H., Malick A. W., Rhodes C. T. Controlled drug delivery by biodegradable poly(ester) devices: different preparative approaches. Drug Del. Ind. Pharm. 1998; 24: 703–727, [CSA]
   PubMed Web of Science ®Google Scholar
• Jallin R., Nixon J. R. Microencapsulation using poly(DL-Lactic acid) II: effect of polymer molecular weight on the microcapsule properties. J. Microencap. 1990; 7: 245–254, [CSA]
   PubMed Web of Science ®Google Scholar
• James E., Singh G., Larry L., Vinod P. Method to compare dissolution profiles and a rationale for wide dissolution specification for metoprolol tartrate tablets. J. Pharmaceut. Sci. 1994; 86: 690–700, [CSA]
   Google Scholar
• Jeffery H., Davis S. S., O'Hagan D. T. The preparation and characterization of poly (lactic-co-glycolide) microparticles: I. Oil-in-water emulsion solvent evaporation. Int. J. Pharmaceut. 1991; 77: 169–176, [CROSSREF], [CSA]
   Web of Science ®Google Scholar
• Karceski S., Morrell M., Carpenter D. The expert consensus guideline series: treatment of epilepsy. Epilepsy Behav, 2001; 2: A1–A50, [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Kawashima Y., Yamamoto H., Takeuchi H., Hino T., Hiwa T. Properties of a peptide containing DL-lactide/glycolide copolymer nanospheres prepared by novel emulsion solvent diffusion methods. Euro. J. Pharmaceut. Biopharmaceut. 1998; 45: 41–48, [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Krahn F. U., Mielck J. B. Effect of type and extent of crystalline order on chemical and physical stabilityof carbamazepine. Int. J. Pharmaceut. 1989; 53: 25–34, [CROSSREF], [CSA]
   Web of Science ®Google Scholar
• Lambert W. J., Peck K. D. Development of an in situ forming biodegradable poly-lactide-co-glycolide system for the controlled release of protein. J. Control. Rel. 1995; 33: 189–195, [CROSSREF], [CSA]
   Web of Science ®Google Scholar
• Leppik I. E. Contemporary Diagnosis and Management of the Patient with Epilepsy 6th ed. Handbooks in Healthcare, Newtown, PA 2002; 119–127
   Google Scholar
• Mauduit J., Bukh N., Vert M. Gentamicin/poly(lactic acid) blends aimed at sustained release local antibiotic therapy administered per-operatively: III. The case of gentamicin sulfate films prepared from high and low molecular weight poly (d, l-lactic acids). J. Control. Rel. 1993; 25: 43–49, [CROSSREF], [CSA]
   Web of Science ®Google Scholar
• Meyer M. C., Straughn A. B., Jarivi E. J., Woods G. C., Pelsor F. R., Shah V. P. The bioinequivalance of carbamazepine tablets with a history of clinical failures. Pharmaceut. Res. 1992; 9: 1612–1616, [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Miller A., Bergey G., Krauss G. Conversion from immediate- to extended-release carbamazepine markedly reduces CNS-related side effects in patients with partial-onset epilepsy. Epilepsia 2002; 43(Suppl 7)196, [CSA]
   PubMedGoogle Scholar
• Naima Z., Toscani S., Gines-Dorado J.-M., Chemtob C., Cèolin R., Duguè J. Interactions between carbamazepine and polyethylene glycol (PEG) 6000: characterizations of the physical solid dispersed and eutectic mixtures. Eur. J. Pharmaceut. Sci. 2001; 12: 395–404, [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Passerini N., Craig D. Q. M. Characterization of ciclosporin A loaded poly (D,L-Lactide-Co-glycolide) microspheres using modulated temperature differential scanning calorimetry. J. Pharm. Pharmacol. 2002; 54: 913–919, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Pedley T. A., Scheuer M. L., Walczak T. S. Epilepsy. Merritt's Textbook of Neurology, 9th ed., L. P. Rowland. Williams & Wilkins, Baltimore 1995; 845–68
   Google Scholar
• Peppas N. A. Analysis of Fickian and non-Fickian drug release from polymers. Pharmaceutica Acta Helvetia 1985; 60: 110–111, [CSA]
   PubMedGoogle Scholar
• Radwan M. A., Abu El-Enein H. In vitro release and stereoselective disposition of flurbiprofen loaded to poly (D,L-lactide-co-glycolide) nanoparticles in Rats. Chirality 2004; 16: 119–125, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Rafiee-Tehrani M., Zehtabchii B., Aghaii-Moghaddam F., Mehdizadehi A. Effect of different polymers on the release characteristics of carbamazepine from stable controlled-release tablets prepared by the air suspension and wet granulation techniques. Acta Pharmaceutica 2000; 50: 291–301, [CSA]
   Google Scholar
• Ramsay R. E., McManus D. Q., Guterman A., Briggle T. H., Vazquez D., Perchalski R. Carbamazepine metabolism in humans: effect of concurrent anticonvulsant therapy. Therapeut. Drug Monit. 1990; 12: 235–241, [CSA]
   PubMed Web of Science ®Google Scholar
• Ritger P. L., Peppas N. A. A simple equation for description of solute release II. Fickian and anomalous release from swellable device. J. Control. Rel. 1987; 5: 37–42, [CROSSREF], [CSA]
   Google Scholar
• Rustichelli C., Gamberini G., Ferioli V., Gamberini M. C., Ficarra R., Tommasini S. Solid-state study of polymorphic drugs: carbamazepine. J. Pharmaceut. Biomed. Anal. 2000; 23: 41–54, [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Sanders L. M., Kell B. A., McRae G. I., Whitehead G. W. Prolonged controlled-release of nafarelin, a luteinizing hormone-releaseing hormone analogue, from a biodegradable polymeric implants: influence of composition and molecular weight of polymer. J. Pharmaceut. Sci. 1986; 75: 356–360, [CSA]
   PubMed Web of Science ®Google Scholar
• Shih C. Chain-end scission in acid catalyzed hydrolysis of poly (d,l-lactide) in solution. J. Control. Rel. 1995; 34: 9–15, [CROSSREF], [CSA]
   Web of Science ®Google Scholar
• Thakker K. M., Mangat S., Garnett W. R., Levy R. H., Kochak G. M. Comparative bioavailability and steady state fluctuations of Tegretol commercial and arbamazepine OROS tablets in adult and pediatric epileptic patients. Biopharmaceut. Drug Disp. 1992; 13: 559–69, [CSA]
   PubMed Web of Science ®Google Scholar
• Vert M. Structure et comportement des polymères. Exemples des polymers biorésorbables. S.T.P. Pharma Science 1987; 3: 216–222, [CSA]
   Google Scholar
• Vert M., Li S., Garreau H. More about the degradation of LA/GA derived matrices in aqueous media. J. Control. Rel. 1991; 19: 15–26, [CROSSREF], [CSA]
   Google Scholar
• Vert M., Schwach G., Engel R., Coudane J. Something new in the field of PLA/GA bioresorbable polymers. J. Control. Rel. 1998; 53: 85–92, [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Vickrey B. G. Special issue: advancesin the measurement of health-related quality of life in epilepsy. Qual. Life Res. 1995; 4: 83–85, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Watts P. J., Davies M. C., Melia C. D. Microencapsulation using emulsification/solvent evaporation: an overview of techniques and applications. Crit. Rev. Therap Drug Carrier Sys. 1990; 7: 235–259, [CSA]
   PubMed Web of Science ®Google Scholar
• Yen S. Y., Sung K. C., Wang J. J., Hu O. Y. Controlled release of nalbuphine propionate from biodegradable microspheres: in vitro and in vivo studies. Int. J. Pharmaceut. 2001; 220: 91–99, [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar